I am glad they didn't.

I think we can all agree that without prices that make these lifesaving drugs accessible, innovation for the sake of innovation is not why we were sent to Congress.

Need to have certainty that whatever they are selling they know what it costs them themselves.

I commend you all for your bipartisan consideration and the passage of H.R. 2296, the More Efficient Tools to Realize Information for Consumers Act.

I look forward to working with this committee, the Centers for Medicare and Medicaid Services, our Senate colleagues, and the President to address these fees that are hurting our seniors, our small businesses, and our taxpayers.

The Fair Pricing Act seeks to reduce prescription drug costs by--for seniors by bringing all negotiated price concessions at the point of sale.

Addressing these fees would not only refocus an important part of our drug supply chain to improve patient health, but combat the financial uncertainty that these small businesses face.

We are seeing our community pharmacies across the country disappear.

These unpredictable fees increase patient cost sharing for drugs, pushing them into coverage gaps.

A recent PwC report estimated that by 2030, AI and machine-learning technologies could increase North American GDP by $3.7 trillion and could increase global GDP by $15.7 trillion.

During one of the most divisive times in American history, I rise today in a moment of American optimism. In this freshly minted 116th Congress, the most diverse in our history, I welcome all new Members, young and old; Democrats and…

Today we speak about the most egregious acts from this administration, one after another after another, but I will not forget about our children. I rise today to tell my fellow Members of Congress that I am appalled over reports of the…